Nanjing Gaoxin Hospital is a medical institution in Nanjing, China, that operates a dedicated Phase I Clinical Trial Site. The facility is equipped to conduct clinical research, including bioequivalence studies, and adheres to strict safety and regulatory standards for clinical trials.
CLASSIFICATION
SIZE & FINANCIALS
Ownership:private
Status:operating
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1
Modalities:Small molecule
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Shanghai Chenpon Pharmaceutical Co., Ltd. (Collaborator on bioequivalence studies)
COMPETITION
Position:Niche Player
LINKS
Website:cropro.cn
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Nanjing Gaoxin Hospital (Phase I Clinical Trial Site) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Nanjing Gaoxin Hospital (Phase I Clinical Trial Site). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.